Selective Estrogen Receptor Degraders (SERDs): A Promising Treatment to Overcome Resistance to Endocrine Therapy in ERα-Positive Breast Cancer
ACS Med Chem Lett
.
2017 Oct 31;8(11):1129-1131.
doi: 10.1021/acsmedchemlett.7b00424.
eCollection 2017 Nov 9.
Author
Ahmed F Abdel-Magid
1
Affiliation
1
Therachem Research Medilab (India) Pvt. Ltd., Jaipur, India.
PMID:
29152041
PMCID:
PMC5682615
DOI:
10.1021/acsmedchemlett.7b00424
No abstract available
Publication types
Editorial